Search Results - "de Jong, Andrea E."

Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn’s disease patients with prior failure to anti‐TNF treatment by Biemans, Vince B. C., Woude, C. Janneke, Dijkstra, Gerard, Meulen‐de Jong, Andrea E., Löwenberg, Mark, Boer, Nanne K., Oldenburg, Bas, Srivastava, Nidhi, Jansen, Jeroen M., Bodelier, Alexander G. L., West, Rachel L., Vries, Annemarie C., Haans, Jeoffrey J. L., Jong, Dirk, Hoentjen, Frank, Pierik, Marieke J.

“…Summary Background Both vedolizumab and ustekinumab can be considered for the treatment of Crohn’s disease (CD) when anti‐TNF treatment fails. However,…”
Get full text

Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry by Biemans, Vince B. C., Sleutjes, Jasmijn A. M., Vries, Annemarie C., Bodelier, Alexander G. L., Dijkstra, Gerard, Oldenburg, Bas, Löwenberg, Mark, Bodegraven, Adriaan A., Meulen‐de Jong, Andrea E., Boer, Nanne K. H., Srivastava, Nidhi, West, Rachel L., Römkens, Tessa E. H., Horjus Talabur Horje, Carmen S., Jansen, Jeroen M., Woude, C. Janneke, Hoekstra, Jildou, Weersma, Rinse K., Schaik, Fiona D. M., Hoentjen, Frank, Pierik, Marieke J., Fidder, H. H., Ponsioen, C. Y., Duijvestein, M., Romberg‐Camps, M. J. L., Maljaars, P. W. J., Bouma, G., Marel, S., Jong, D. J., Haans, J. J. L.

“…Summary Background Tofacitinib is a Janus kinase inhibitor approved for the treatment of ulcerative colitis (UC). Aim To evaluate effectiveness, safety and use…”
Get full text

Effectiveness and safety of tofacitinib for ulcerative colitis: two‐year results of the ICC Registry by Straatmijer, Tessa, Schaik, Fiona D. M., Bodelier, Alexander G. L., Visschedijk, Marijn, Vries, Annemarie C., Ponsioen, Cyriel Y., Pierik, Marieke, Bodegraven, Ad A., West, Rachel L., Boer, Nanne K. H., Srivastava, Nidhi, Romkens, Tessa E. H., Hoekstra, Jildou, Oldenburg, Bas, Dijkstra, Gerard, Woude, Janneke C., Löwenberg, Mark, Mujagic, Zlatan, Biemans, Vince B. C., Meulen‐de Jong, Andrea E., Duijvestein, Marjolijn

“…Summary Background Tofacitinib is an oral Janus kinase (JAK) inhibitor and is registered for the treatment of ulcerative colitis (UC). The effectiveness of…”
Get full text

Prior Colorectal Neoplasia Is Associated With Increased Risk of Ileoanal Pouch Neoplasia in Patients With Inflammatory Bowel Disease by Derikx, Lauranne A.A.P, Kievit, Wietske, Drenth, Joost P.H, de Jong, Dirk J, Ponsioen, Cyriel Y, Oldenburg, Bas, van der Meulen–de Jong, Andrea E, Dijkstra, Gerard, Grubben, Marina J.A.L, van Laarhoven, Cornelis J.H.M, Nagtegaal, Iris D, Hoentjen, Frank

“…Background & Aims Although restorative proctocolectomy with ileal pouch–anal anastomosis (IPAA) substantially reduces the risk of colorectal cancer in patients…”
Get full text

Prognostic Value of the Modified Rutgeerts Score for Long-Term Outcomes After Primary Ileocecal Resection in Crohn's Disease by Bak, Michiel T J, Ten Bokkel Huinink, Sebastiaan, Erler, Nicole S, Bodelier, Alexander G L, Dijkstra, Gerard, Romberg-Camps, Mariëlle, de Boer, Nanne K H, Hoentjen, Frank, Stassen, Laurents P S, van der Meulen-de Jong, Andrea E, West, Rachel L, van Ruler, Oddeke, van der Woude, C Janneke, de Vries, Annemarie C

“…The prognostic value of the modified Rutgeerts score (mRS) in patients with Crohn's disease (CD) needs to be further elucidated. This study assessed the…”
Get full text

Prevalence of-and risk factors for work disability in Dutch patients with inflammatory bowel disease by Spekhorst, Lieke M, Oldenburg, Bas, van Bodegraven, Ad A, de Jong, Dirk J, Imhann, Floris, van der Meulen-de Jong, Andrea E, Pierik, Marieke J, van der Woude, Janneke C, Dijkstra, Gerard, D'Haens, Geert, Löwenberg, Mark, Weersma, Rinse K, Festen, Eleonora A M

“…AIM To determine the prevalence of work disability in inflammatory bowel disease(IBD), and to assess risk factors associated with work disability.METHODS For…”
Get full text

One to 2-Year Surveillance Intervals Reduce Risk of Colorectal Cancer in Families With Lynch Syndrome by Vasen, Hans F.A, Abdirahman, Mohamed, Brohet, Richard, Langers, Alexandra M.J, Kleibeuker, Jan H, van Kouwen, Mariette, Koornstra, Jan Jacob, Boot, Henk, Cats, Annemieke, Dekker, Evelien, Sanduleanu, Silvia, Poley, Jan–Werner, Hardwick, James C.H, de Vos tot Nederveen Cappel, Wouter H, van der Meulen–de Jong, Andrea E, Tan, T. Gie, Jacobs, Maarten A.J.M, Mohamed, Faig Lall A, de Boer, Sijbrand Y, van de Meeberg, Paul C, Verhulst, Marie–Louise, Salemans, Jan M, van Bentem, Nico, Westerveld, B. Dik, Vecht, Juda, Nagengast, Fokko M

“…Background & Aims Two percent to 4% of all cases of colorectal cancer (CRC) are associated with Lynch syndrome. Dominant clustering of CRC (non-Lynch syndrome)…”
Get full text

Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study by Biemans, Vince B C, van der Meulen - de Jong, Andrea E, van der Woude, Christine J, Löwenberg, Mark, Dijkstra, Gerard, Oldenburg, Bas, de Boer, Nanne K H, van der Marel, Sander, Bodelier, Alexander G L, Jansen, Jeroen M, Haans, Jeoffrey J L, Theeuwen, Rosaline, de Jong, Dirk, Pierik, Marie J, Hoentjen, Frank

“…Abstract Background and Aims Ustekinumab is approved for the treatment of Crohn’s disease [CD]. Systematically registered prospective real-world data are…”
Get full text

Standardization of mesenchymal stromal cell therapy for perianal fistulizing Crohn’s disease by Molendijk, Ilse, van der Meulen – de Jong, Andrea E, Verspaget, Hein W, Veenendaal, Roeland A, Hommes, Daniel W, Bonsing, Bert A, Peeters, Koen C.M.J

“…BACKGROUNDLocal administration of mesenchymal stromal cells (MSCs) into the fistula tract seems to improve patient outcome in perianal fistulas due to Crohn’s…”
Get full text

Smoking and colorectal neoplasia in patients with inflammatory bowel disease: Dose-effect relationship by Wijnands, Anouk M, Elias, Sjoerd G, Dekker, Evelien, Fidder, Herma H, Hoentjen, Frank, Ten Hove, Joren R, Maljaars, P W Jeroen, van der Meulen-de Jong, Andrea E, Mooiweer, Erik, Ouwehand, Renske J, Penning de Vries, Bas B L, Ponsioen, Cyriel Y, van Schaik, Fiona D M, Oldenburg, Bas

“…Prior studies on the effect of smoking on the risk of colitis-associated colorectal neoplasia (CRN) have reported conflicting results. We aimed to further…”
Get full text

Comparison of Patients’ and Doctors’ Reports on Health‐related Quality of Life in Celiac Disease by Vriezinga, Sabine L., Farih, Nora, Meulen‐de Jong, Andrea E., Putter, Hein, Rings, Edmond H.H.M., Schaart, Maaike W., Schweizer, Joachim J., Wessels, Margreet M.S., Mearin, M. Luisa

“…ABSTRACT Objective: To investigate whether implementation of a celiac disease (CD)–specific health‐related quality of life (HRQOL) questionnaire would add…”
Get full text

Illness Perceptions and Depression Are Associated with Health-Related Quality of Life in Youth with Inflammatory Bowel Disease by Stapersma, Luuk, van den Brink, Gertrude, van der Ende, Jan, Bodelier, Alexander G., van Wering, Herbert M., Hurkmans, Pamela C. W. M., Mearin, M. Luisa, van der Meulen–de Jong, Andrea E., Escher, Johanna C., Utens, Elisabeth M. W. J.

“…Background In youth with inflammatory bowel disease (IBD), health-related quality of life (HRQOL) has been shown to be affected by individual disease factors…”
Get full text

Identification of a Disease-Associated Network of Intestinal Immune Cells in Treatment-Naive Inflammatory Bowel Disease by van Unen, Vincent, Ouboter, Laura F., Li, Na, Schreurs, Mette, Abdelaal, Tamim, Kooy-Winkelaar, Yvonne, Beyrend, Guillaume, Höllt, Thomas, Maljaars, P. W. Jeroen, Mearin, M. Luisa, Mahfouz, Ahmed, Witte, Anne M. C., Clemens, Cornelis H. M., Abraham, Sunje, Escher, Johanna C., Lelieveldt, Boudewijn P. F., Pascutti, M. Fernanda, van der Meulen – de Jong, Andrea E., Koning, Frits

“…Chronic intestinal inflammation underlies inflammatory bowel disease (IBD). Previous studies indicated alterations in the cellular immune system; however, it…”
Get full text

Mass Cytometry of the Human Mucosal Immune System Identifies Tissue- and Disease-Associated Immune Subsets by van Unen, Vincent, Li, Na, Molendijk, Ilse, Temurhan, Mine, Höllt, Thomas, van der Meulen-de Jong, Andrea E., Verspaget, Hein W., Mearin, M. Luisa, Mulder, Chris J., van Bergen, Jeroen, Lelieveldt, Boudewijn P.F., Koning, Frits

“…Inflammatory intestinal diseases are characterized by abnormal immune responses and affect distinct locations of the gastrointestinal tract. Although the role…”
Get full text

Cohort profile: design and first results of the Dutch IBD Biobank: a prospective, nationwide biobank of patients with inflammatory bowel disease by Spekhorst, Lieke M, Imhann, Floris, Festen, Eleonora AM, Bodegraven, Ad A van, Boer, Nanne KH de, Bouma, Gerd, Fidder, Herma H, D’Haens, Geert, Hoentjen, Frank, Hommes, Daan W, Jong, Dirk J de, Löwenberg, Mark, Maljaars, PW Jeroen, Meulen-de Jong, Andrea E van der, Oldenburg, Bas, Pierik, Marieke J, Ponsioen, Cyriel Y, Stokkers, Pieter C, Verspaget, Hein W, Visschedijk, Marijn C, van der Woude, C Janneke, Dijkstra, Gerard, Weersma, Rinse K

“…PurposeThe Dutch IBD Biobank aims to facilitate the discovery of predictors for individual disease course and treatment response in patients with inflammatory…”
Get full text

Crohn's Disease-Associated and Cryptoglandular Fistulas: Differences and Similarities by Zhou, Zhou, Ouboter, Laura F, Peeters, Koen C M J, Hawinkels, Lukas J A C, Holman, Fabian, Pascutti, Maria F, Barnhoorn, Marieke C, van der Meulen-de Jong, Andrea E

“…Perianal fistulas are defined as pathological connections between the anorectal canal and the perianal skin. Most perianal fistulas are cryptoglandular…”
Get full text

Ustekinumab Trough Concentrations Are Associated with Biochemical Outcomes in Patients with Crohn’s Disease by Straatmijer, Tessa, Biemans, Vince B. C., Moes, Dirk Jan A. R., Hoentjen, Frank, ter Heine, Rob, Maljaars, P. W. Jeroen, Theeuwen, Rosaline, Pierik, Marieke, Duijvestein, Marjolijn, van der Meulen-de Jong, Andrea E.

“…Objective It is unknown whether ustekinumab (UST) levels can predict clinical outcomes in Crohn’s disease (CD) patients. We assessed the exposure–response…”
Get full text

Vedolizumab for Inflammatory Bowel Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registry - Vedolizumab by Biemans, Vince B C, van der Woude, C Janneke, Dijkstra, Gerard, van der Meulen-de Jong, Andrea E, Oldenburg, Bas, de Boer, Nanne K, Löwenberg, Mark, Srivastava, Nidhi, Bodelier, Alexander G L, West, Rachel L, Jansen, Jeroen M, de Vries, Annemarie C, Haans, Jeoffrey J L, de Jong, Dirk J, Pierik, Marie J, Hoentjen, Frank

“…Prospective data of vedolizumab treatment for patients with inflammatory bowel disease (IBD) beyond 1 year of treatment is scarce but needed for clinical…”
Get full text

Local administration of mesenchymal stromal cells is safe and modulates the immune compartment in ulcerative proctitis by Ouboter, Laura F, Barnhoorn, Marieke C, Verspaget, Hein W, Plug, Leonie, Pool, Emma S, Szuhai, Karoly, Hawinkels, Lukas Jac, van Pel, Melissa, Zwaginga, Jaap Jan, Roelen, Dave, Koning, Frits, Pascutti, M Fernanda, van der Meulen-de Jong, Andrea E

“…BACKGROUNDDue to their immunoregulatory and tissue regenerative features, mesenchymal stromal cells (MSCs) are a promising novel tool for the management of…”
Get full text

Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer by Lange, Christopher P E, Campan, Mihaela, Hinoue, Toshinori, Schmitz, Roderick F, van der Meulen-de Jong, Andrea E, Slingerland, Hilde, Kok, Peter J M J, van Dijk, Cornelis M, Weisenberger, Daniel J, Shen, Hui, Tollenaar, Robertus A E M, Laird, Peter W

“…There is an increasing demand for accurate biomarkers for early non-invasive colorectal cancer detection. We employed a genome-scale marker discovery method to…”
Get full text